Neurocrine Biosciences NBIX
NASDAQ NBIX
$174.41 +5.27 (+3.12%)
At close: Nov 11, 2026 · 4:00 PM EST

Neurocrine Biosciences (NBIX) Notes Payables (2010 - 2019)

Updated

Analysis

Neurocrine Biosciences (NBIX) Notes Payables (2010 - 2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Neurocrine Biosciences 17.13 Bn 13.21 Bn 1.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 97.50 Mn
Jun 30, 2018 37.10 Mn
Sep 30, 2017 66.70 Mn
Jun 30, 2017 95.60
Mar 31, 2017 44.40 Mn
Sep 30, 2016 44.10 Mn
Jun 30, 2016 30.70 Mn
Sep 30, 2015 23.90 Mn
Jun 30, 2015 23.90 Mn
Sep 30, 2014 15.50 Mn
Jun 30, 2014 15.50 Mn
Mar 31, 2014 20.00 Mn
Sep 30, 2010 26.12 Mn
Jun 30, 2010 7.48 Mn
API Access

Neurocrine Biosciences Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=NBIX&period=max&api_key=YOUR_API_KEY